{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T22:43:22Z","timestamp":1781477002508,"version":"3.54.1"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T00:00:00Z","timestamp":1520812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Scleroderma Clinical Trials Consortium"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Arthritis"},{"name":"Musculoskeletal and Skin Diseases","award":["K24 AR063120"],"award-info":[{"award-number":["K24 AR063120"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,1]]},"DOI":"10.1093\/rheumatology\/key026","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T20:12:36Z","timestamp":1519157556000},"page":"18-26","source":"Crossref","is-referenced-by-count":62,"title":["The patient experience of Raynaud\u2019s phenomenon in systemic sclerosis"],"prefix":"10.1093","volume":"58","author":[{"given":"John D","family":"Pauling","sequence":"first","affiliation":[{"name":"Department of Pharmacy and Pharmacology, University of Bath, Bath, UK"},{"name":"Royal National Hospital for Rheumatic Diseases (part of Royal United Hospitals), Upper Borough Walls, Bath, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley Ann","family":"Saketkoo","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Tulane Medical Center, New Orleans, LA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Matucci-Cerinic","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy"},{"name":"Department of Geriatric Medicine, Division of Rheumatology, AOUC, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6727-1273","authenticated-orcid":false,"given":"Francesca","family":"Ingegnoli","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, ASST Pini, Department of Clinical Sciences and Community Health, Universita degli Studi di Milano, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Khanna","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, University of Michigan, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,12]]},"reference":[{"key":"key\n\t\t\t\t2018121406541590200_key026-B1","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B2","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/art.37988","article-title":"Review: evidence that systemic sclerosis is a vascular disease","volume":"65","author":"Matucci-Cerinic","year":"2013","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B3","first-page":"879","article-title":"Geographic variation in the prevalence of Raynaud\u2019s phenomenon: a 5 region comparison","volume":"24","author":"Maricq","year":"1997","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B4","doi-asserted-by":"crossref","first-page":"371960","DOI":"10.1155\/2015\/371960","article-title":"Uniphasic blanching of the fingers, abnormal capillaroscopy in nonsymptomatic digits, and autoantibodies: expanding options to increase the level of suspicion of connective tissue diseases beyond the classification of Raynaud\u2019s phenomenon","volume":"2015","author":"Ingegnoli","year":"2015","journal-title":"J Immunol Res"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/acr.20108","article-title":"Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis","volume":"62","author":"Schieir","year":"2010","journal-title":"Arthritis Care Res"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B6","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/art.10486","article-title":"Measuring disease activity and functional status in patients with scleroderma and Raynaud\u2019s phenomenon","volume":"46","author":"Merkel","year":"2002","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/msc.1047","article-title":"Similar problem in the activities of daily living but different experience: a qualitative analysis in six rheumatic conditions and eight European countries","volume":"12","author":"Stamm","year":"2014","journal-title":"Musculoskeletal Care"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/msc.1051","article-title":"Skin and mucosa care in systemic sclerosis\u2013patients\u2019 and family caregivers\u2019 experiences and expectations of a specific education programme: a qualitative study","volume":"11","author":"Kocher","year":"2013","journal-title":"Musculoskeletal Care"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B9","first-page":"1718","article-title":"Disease and symptom burden in systemic sclerosis: a patient perspective","volume":"34","author":"Suarez-Almazor","year":"2007","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B10","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1007\/s00296-011-2230-2","article-title":"Living with scleroderma: patients\u2019 perspectives, a phenomenological study","volume":"32","author":"Cinar","year":"2012","journal-title":"Rheumatol Int"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B11","volume-title":"Selected monographs: Raynaud's two essays on local asphyxia of the extremities","author":"Raynaud","year":"1888"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0021-9681(86)90109-8","article-title":"Prevalence of Raynaud phenomenon in the general population. A preliminary study by questionnaire","volume":"39","author":"Maricq","year":"1986","journal-title":"J Chronic Dis"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/rheumatology\/32.5.357","article-title":"Validity and reliability of three methods used in the diagnosis of Raynaud\u2019s phenomenon. The UK Scleroderma Study Group","volume":"32","author":"Brennan","year":"1993","journal-title":"Br J Rheumatol"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B14","first-page":"485","article-title":"Raynaud\u2019s phenomenon: a proposal for classification","volume":"10","author":"LeRoy","year":"1992","journal-title":"Clin Exp Rheumatol"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B15","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B16","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaut.2014.01.020","article-title":"International consensus criteria for the diagnosis of Raynaud\u2019s phenomenon","volume":"48-49","author":"Maverakis","year":"2014","journal-title":"J Autoimmun"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B18","first-page":"454","article-title":"Diagnosis of Raynaud\u2019s phenomenon assisted by color charts","volume":"15","author":"Maricq","year":"1988","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B19","first-page":"171","article-title":"The diagnostic value of clinical signs and symptoms in patients with Raynaud\u2019s phenomenon. A cross-sectional study","volume":"37","author":"Wollersheim","year":"1990","journal-title":"Neth J Med"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B20","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/rheumatology\/kes315","article-title":"Systemic sclerosis without antinuclear antibodies or Raynaud's phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"52","author":"Schneeberger","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B21","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0025-7125(16)30623-X","article-title":"Raynaud\u2019s phenomenon and disease","volume":"73","author":"Cardelli","year":"1989","journal-title":"Med Clin North Am"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/rheumatology\/ken221","article-title":"Sparing of the thumb in Raynaud\u2019s phenomenon","volume":"47","author":"Chikura","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B23","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3899\/jrheum.091117","article-title":"Thumb involvement in Raynaud\u2019s phenomenon as an indicator of underlying connective tissue disease","volume":"37","author":"Chikura","year":"2010","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B24","first-page":"1734","article-title":"Seasonal variation of Raynaud\u2019s phenomenon secondary to systemic sclerosis","volume":"26","author":"Watson","year":"1999","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B25","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/rheumatology\/kev002","article-title":"Prediction and impact of attacks of Raynaud\u2019s phenomenon, as judged by patient perception","volume":"54","author":"Hughes","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B26","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1136\/bmj.287.6404.1499","article-title":"Role of cold and emotional stress in Raynaud\u2019s disease and scleroderma","volume":"287","author":"Freedman","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0022-3999(85)90054-6","article-title":"Effects of general and thematically relevant stressors in Raynaud\u2019s disease","volume":"29","author":"Freedman","year":"1985","journal-title":"J Psychosom Res"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1037\/0022-006X.51.4.539","article-title":"Behavioral treatment of Raynaud's disease","volume":"51","author":"Freedman","year":"1983","journal-title":"J Consult Clin Psychol"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B29","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1002\/art.10685","article-title":"Cigarette smoking as a significant risk factor for digital vascular disease in patients with systemic sclerosis","volume":"46","author":"Harrison","year":"2002","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B30","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/art.30071","article-title":"Cigarette smoking in patients with systemic sclerosis","volume":"63","author":"Hudson","year":"2011","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B31","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/1529-0131(199804)41:4<670::AID-ART14>3.0.CO;2-I","article-title":"Oral iloprost treatment in patients with Raynaud\u2019s phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study","volume":"41","author":"Wigley","year":"1998","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B32","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/rheumatology\/37.9.952","article-title":"Oral iloprost in Raynaud\u2019s phenomenon secondary to systemic sclerosis: a multicentre, placebo-controlled, dose-comparison study","volume":"37","author":"Black","year":"1998","journal-title":"Br J Rheumatol"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B33","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.3899\/jrheum.090270","article-title":"Randomized placebo-controlled crossover trial of tadalafil in Raynaud\u2019s phenomenon secondary to systemic sclerosis","volume":"36","author":"Schiopu","year":"2009","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7326\/0003-4819-120-3-199402010-00004","article-title":"Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study","volume":"120","author":"Wigley","year":"1994","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B35","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/rheumatology\/keq291","article-title":"Efficacy of tadalafil in secondary Raynaud\u2019s phenomenon resistant to vasodilator therapy: a double-blind randomized cross-over trial","volume":"49","author":"Shenoy","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B36","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/art.30195","article-title":"Modified-release sildenafil reduces Raynaud\u2019s phenomenon attack frequency in limited cutaneous systemic sclerosis","volume":"63","author":"Herrick","year":"2011","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B37","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/art.24351","article-title":"MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud\u2019s phenomenon: a randomized, controlled trial","volume":"60","author":"Chung","year":"2009","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B38","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1161\/CIRCULATIONAHA.104.523324","article-title":"Sildenafil in the treatment of Raynaud\u2019s phenomenon resistant to vasodilatory therapy","volume":"112","author":"Fries","year":"2005","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B39","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3899\/jrheum.141437","article-title":"Use of laser speckle contrast imaging to assess digital microvascular function in primary Raynaud phenomenon and systemic sclerosis: a comparison using the Raynaud Condition Score Diary","volume":"42","author":"Pauling","year":"2015","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3233\/WOR-2012-1420","article-title":"Experiencing work as a daily challenge: the case of scleroderma","volume":"44","author":"Mendelson","year":"2013","journal-title":"Work"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B41","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1080\/09638280601029480","article-title":"Become your own advocate: advice from women living with scleroderma","volume":"29","author":"Mendelson","year":"2007","journal-title":"Disabil Rehabil"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B42","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/acr.21858","article-title":"Evaluation of test characteristics for outcome measures used in Raynaud\u2019s phenomenon clinical trials","volume":"65","author":"Gladue","year":"2013","journal-title":"Arthritis Care Res"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B43","article-title":"Attitudes toward patient-reported outcome instruments for the assessment of Raynaud\u2019s phenomenon in systemic sclerosis","volume":"68(Suppl 10)","author":"Pauling","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B44","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1136\/annrheumdis-2012-202836","article-title":"Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud\u2019s phenomenon: systematic review and meta-analysis of randomised trials","volume":"72","author":"Roustit","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B45","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/ard.50.Suppl_4.839","article-title":"Raynaud\u2019s phenomenon: its relevance to scleroderma","volume":"50 (Suppl 4)","author":"Belch","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B46","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/art.1780401110","article-title":"The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time","volume":"40","author":"Steen","year":"1997","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B47","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/ard.2009.107706","article-title":"The minimally important difference and patient acceptable symptom state for the Raynaud\u2019s condition score in patients with Raynaud\u2019s phenomenon in a large randomised controlled clinical trial","volume":"69","author":"Khanna","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B48","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3899\/jrheum.121212","article-title":"Systemic sclerosis in Canada's North American Native population: assessment of clinical and serological manifestations","volume":"40","author":"Bacher","year":"2013","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B49","first-page":"S-88","article-title":"Frequency and impact of disease symptoms experienced by patients with systemic sclerosis from five European countries","volume":"32(6 Suppl 86)","author":"Willems","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B50","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/rheumatology\/keq310","article-title":"Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey","volume":"50","author":"Bassel","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1590\/S0482-50042013000500007","article-title":"Symptoms of disease and psychological adaptation in Brazilian scleroderma patients","volume":"53","author":"Leite","year":"2013","journal-title":"Rev Bras Reumatol"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B52","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/03009740802695466","article-title":"A longitudinal follow-up of hand involvement and activities of daily living in early systemic sclerosis","volume":"38","author":"Sandqvist","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B53","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/rheumatology\/kep413","article-title":"Effect of the dual endothelin receptor antagonist bosentan on Raynaud\u2019s phenomenon secondary to systemic sclerosis: a double-blind prospective, randomized, placebo-controlled pilot study","volume":"49","author":"Nguyen","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semarthrit.2016.02.005","article-title":"Impaired quality of life in systemic sclerosis and patient perception of the disease: a large international survey","volume":"46","author":"Frantz","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B55","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1136\/ard.2010.148767","article-title":"Concepts of functioning and health important to people with systemic sclerosis: a qualitative study in four European countries","volume":"70","author":"Stamm","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B56","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/acr.22819","article-title":"Development and validation of the Body Concealment Scale for Scleroderma","volume":"68","author":"Jewett","year":"2016","journal-title":"Arthritis Care Res"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B57","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/rheumatology\/ker324","article-title":"Managing work life with systemic sclerosis","volume":"51","author":"Sandqvist","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B58","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00296-008-0556-1","article-title":"Management of cutaneous vascular complications in systemic scleroderma: experience from the German network","volume":"28","author":"Herrgott","year":"2008","journal-title":"Rheumatol Int"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B59","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.semarthrit.2012.01.003","article-title":"Treatment of systemic sclerosis complications: what to use when first-line treatment fails\u2013a consensus of systemic sclerosis experts","volume":"42","author":"Walker","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B60","first-page":"S38","article-title":"Best practices in scleroderma: an analysis of practice variability in SSc centres within the Canadian Scleroderma Research Group (CSRG)","volume":"30(2 Suppl 71)","author":"Harding","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B61","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B62","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3899\/jrheum.110121","article-title":"Agreement with guidelines from a large database for management of systemic sclerosis: results from the Canadian Scleroderma Research Group","volume":"39","author":"Pope","year":"2012","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2018121406541590200_key026-B63","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3899\/jrheum.150382","article-title":"Vasoactive therapy in systemic sclerosis: real-life therapeutic practice in more than 3000 patients","volume":"43","author":"Moinzadeh","year":"2016","journal-title":"J Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/58\/1\/18\/27144603\/key026.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T16:10:25Z","timestamp":1660493425000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/58\/1\/18\/4930650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,12]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,3,12]]},"published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/key026","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1]]},"published":{"date-parts":[[2018,3,12]]}}}